Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilars: Extrapolation for oncology.
Curigliano G, O'Connor DP, Rosenberg JA, Jacobs I. Curigliano G, et al. Crit Rev Oncol Hematol. 2016 Aug;104:131-7. doi: 10.1016/j.critrevonc.2016.06.002. Epub 2016 Jun 15. Crit Rev Oncol Hematol. 2016. PMID: 27354233 Free article. Review.
Talking to patients about biosimilars.
Janjigian YY, Bissig M, Curigliano G, Coppola J, Latymer M. Janjigian YY, et al. Among authors: curigliano g. Future Oncol. 2018 Oct;14(23):2403-2414. doi: 10.2217/fon-2018-0044. Epub 2018 Jun 1. Future Oncol. 2018. PMID: 29856243 Free article. Review.
Biosimilars for breast cancer.
Migliavacca Zucchetti B, Nicolò E, Curigliano G. Migliavacca Zucchetti B, et al. Among authors: curigliano g. Expert Opin Biol Ther. 2019 Oct;19(10):1015-1021. doi: 10.1080/14712598.2019.1638362. Epub 2019 Jul 10. Expert Opin Biol Ther. 2019. PMID: 31248290 Review.
Are Biosimilars the Future of Oncology and Haematology?
Zinzani PL, Dreyling M, Gradishar W, Andre M, Esteva FJ, Boulos S, González Barca E, Curigliano G. Zinzani PL, et al. Among authors: curigliano g. Drugs. 2019 Oct;79(15):1609-1624. doi: 10.1007/s40265-019-01193-y. Drugs. 2019. PMID: 31541401 Review.
767 results